Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

12.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.8K
Bacterial Cell Wall01:22

Bacterial Cell Wall

1.8K
The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
1.8K
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

1.6K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
1.6K
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

714
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
714
Surface Membrane Barriers01:18

Surface Membrane Barriers

2.5K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.5K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytotoxic Activity of Essential Oils from Middle Eastern Medicinal Plants on Malignant Keratinocytes.

Molecules (Basel, Switzerland)·2025
Same author

Rethinking corticosteroids use in oncology.

Frontiers in pharmacology·2025
Same author

Malignant tumors in vagal-innervated organs: Exploring its homeostatic role.

Cancer letters·2025
Same author

Lesser-Known Cyanotoxins: A Comprehensive Review of Their Health and Environmental Impacts.

Toxins·2024
Same author

Plant Metabolomics: The Future of Anticancer Drug Discovery.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

The Relationship among SARS-CoV-2, Vaccine Spike Protein, Renin- Angiotensin System, and Epilepsy.

Infectious disorders drug targets·2024

Related Experiment Video

Updated: Dec 25, 2025

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.5K

Antibacterial Peptides.

Jean-Marc Sabatier1

  • 1Université Aix-Marseille, Institut de Neurophysiopathologie (INP), UMR 7051, 13005 Marseille, France.

Antibiotics (Basel, Switzerland)
|April 1, 2020
PubMed
Summary

Antimicrobial peptides (AMPs) are natural compounds that show promise as drugs against drug-resistant bacteria. These peptides offer a new therapeutic avenue for combating challenging bacterial infections.

Area of Science:

  • Biochemistry and Molecular Biology
  • Microbiology
  • Drug Discovery

Background:

  • Antimicrobial peptides (AMPs) are evolutionarily conserved host defense molecules.
  • AMPs are produced by a wide range of organisms, acting as a first line of defense against pathogens.
  • Their broad-spectrum activity and unique mechanisms of action are of significant interest.

Discussion:

  • AMPs represent a promising class of therapeutic agents against multidrug-resistant (MDR) bacterial strains.
  • Their distinct membrane-disrupting mechanisms differ from conventional antibiotics, potentially circumventing existing resistance pathways.
  • Research is focused on understanding AMP structure-activity relationships and optimizing their efficacy and safety profiles.

Key Insights:

  • Antimicrobial peptides (AMPs) are potent natural compounds with significant therapeutic potential.

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.9K
Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

22.7K

Related Experiment Videos

Last Updated: Dec 25, 2025

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.5K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.9K
Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

22.7K
  • AMPs are effective against both Gram-positive and Gram-negative bacteria, including antibiotic-resistant strains.
  • Their role as potential chemotherapeutic agents is increasingly recognized in combating infectious diseases.

    • Outlook:

    • Further research into AMPs could lead to novel treatments for bacterial infections.
    • Clinical development of AMP-based therapies holds promise for addressing the global challenge of antibiotic resistance.
    • Exploring synergistic combinations of AMPs with existing antibiotics may enhance treatment outcomes.